Access personalized Cholangiocarcinoma (Bile Duct Cancer) care using advanced medical technology, supported by expert specialists and dedicated international patient services.
NMC Specialty Hospital provides Cholangiocarcinoma (Bile Duct Cancer) Treatment using contemporary hepatobiliary and oncology techniques and evidence-based care. Founded in 1975, the JCI, NABH accredited hospital is based in Abu Dhabi, United Arab Emirates, with 104 beds and services for domestic and international patients.
The treatment approach depends on whether the cancer is intrahepatic, perihilar, or distal bile duct cancer and whether it can be surgically removed. Depending on the diagnosis, treatment may involve liver or bile duct surgery, chemotherapy, radiation, targeted therapy, or immunotherapy. Imaging, pathology, and molecular profiling help guide treatment planning.